Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Observational Safety Study of Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis Treated With Rituximab

NCT01613599 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT01613599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01613599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Observational Safety Study of Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis Treated With Rituximab
Lead sponsor
Genentech, Inc.
Phase
Observational
Overall status
Completed
Start date
June 20, 2012
Completion date
April 28, 2017
Enrollment
100 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

granulomatosis with polyangiitis, microscopic polyangiitis